Elisa L Priest is an expert in Critical care at Baylor Scott & White Research Institute (United States). Elisa L Priest has authored 50 publications, the most recent in 2026, and is an investigator in 1 clinical trial. SLR score: 104 (community average: 125). How the SLR is computed.

LeadR Profile

Elisa L Priest Baylor Scott & White Research Institute United States
104 ScienceLeadR Reputation 104
Network Map

Critical care

Subspecialties: Cardiology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 2013 - 2026

Source: PubMed

Baylor Scott & White Research Institute

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 50

Citations

Citations: 1 321 1st author: 1 Last author: 4 Unique author: 0


Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Big data: from signal to action.
PMID 42765926 — big data
Proc (Bayl Univ Med Cent)20260
INSIGHT Model: Explainable Artificial Intelligence for Real-World EHR-Based Screening of Transthyretin Amyloidosis Cardiomyopathy.
PMID 42658135 — natural language processing, intelligence, prealbumin, predictive value of tests, amyloidosis, prevalence, diagnosis, therapeutics, artificial intelligence, cardiomyopathies, transthyretin amyloidosis
JACC Adv20260
Aldosterone dysregulation in essential hypertension.
PMID 42571854 — research design, hypertension, aldosterone, blood, serum, essential hypertension, blood pressure, renin, cardiology, plasma
Am J Cardiol20260
Natural Language Processing Framework in Early Detection of Amyloidosis: The ALARM Study.
PMID 42312784 — natural language processing, language, heart failure, prealbumin, predictive value of tests, amyloidosis, diagnosis
JACC Adv20261
Variation in Lipid Management for Atherosclerotic Cardiovascular Disease Across US Health Systems.
PMID 41717695 — cardiovascular diseases, blood pressure, algorithms, electronic health records, records, therapeutics, hydroxymethylglutaryl-coa reductase inhibitors
Circ Popul Health Outcomes20260

Clinical Studies 1

Sources: ClinicalTrials, EU CTIS

Synthesis

By phase:

N/A 1

By status:

Recruiting 1

By type:

Observational 1

By Monocentric/Multicentric:

monocentric 0
multicentric2to4 1
multicentric5to9 0
multicentricup10 0

Main Topics

Cohort/Consortium Investigators 5

LeadR Networks

Main global connection map